Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Naproxen Delayed-Release Tablets, USP

ANI Pharmaceuticals

02/07/2024 12:58

July 2 (Reuters) - ANI Pharmaceuticals Inc  ANIP.O :
    * ANI PHARMACEUTICALS - U.S. ANNUAL SALES FOR NAPROXEN
TABLETS
ABOUT $36.7 MILLION, BASED ON APRIL MAT IQVIA DATA
    * ANI PHARMACEUTICALS ANNOUNCES THE FDA APPROVAL AND LAUNCH
OF
NAPROXEN DELAYED-RELEASE TABLETS, USP

Source text for Eikon:  ID: 
Further company coverage:  ANIP.O